GENW Genter Capital International Dividend ETF
ETF on NYSE (US) · Actively managed · Listing
Most notable sale · AstraZeneca
AstraZeneca sold out
Shares went from 819 to 0 ($153K → $0). Was 3.2% of the Apr 30, 2026 portfolio.
Most notable buy · AstraZeneca PLC
New position in AstraZeneca PLC
819 units worth $139K. Now 2.7% of the portfolio.
Largest holding: Barclays PLC, unchanged, 9,257 shares ($255K).
| Current positions Top 10 | % of book |
|---|---|
| Barclays PLC BCS $255K · unch. | 5.0% |
| Banco Bilbao Vizcaya Argentaria S.A. BBVA $227K · unch. | 4.4% |
| BNP Paribas SA $225K · +18% units | 4.4% |
| ABB Limited $225K · unch. | 4.4% |
| Mitsubishi UFJ Financial Group, Inc. MUFG $221K · −21% sh | 4.3% |
| Sumitomo Mitsui Financial Group, Inc. SMFG $211K · −24% sh | 4.1% |
| Vodafone Group Plc VOD $168K · unch. | 3.3% |
| Enbridge Inc ENB $165K · unch. | 3.2% |
| Allianz SE $163K · unch. | 3.2% |
| Enel SpA $155K · unch. | 3.0% |
Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Apr 30, 2026.
| Sectors | % of holdings value |
|---|---|
| Financial Services | 25.7% |
| Energy | 7.9% |
| Healthcare | 4.2% |
| Communication Services | 3.3% |
| Technology | 2.8% |
| Consumer Defensive | 2.7% |
| Basic Materials | 2.5% |
| Utilities | 2.3% |
| Other (1) | 1.7% |
| Unclassified | 47.0% |
| Industries | % of holdings value |
|---|---|
| Banks - Diversified | 17.8% |
| Oil & Gas Midstream | 5.7% |
| Drug Manufacturers - General | 4.2% |
| Telecom Services | 3.3% |
| Communication Equipment | 2.8% |
| Financial Conglomerates | 2.7% |
| Tobacco | 2.7% |
| Other (6) | 13.8% |
| Unclassified | 47.0% |
| Initiations 1 | Value |
|---|---|
| AstraZeneca PLC AZN 2.7% of portfolio | $139K |
| Increases 3 | Change |
|---|---|
| MERCEDES-BENZ GROUP MBGYY $71.4K → $145K | 2.2x |
| Imperial Brands PLC $94.3K → $149K | +60% |
| BNP Paribas SA $158K → $225K | +18% |
| Reductions 2 | Change |
|---|---|
| Sumitomo Mitsui Financial Group, Inc. SMFG $229K → $211K | −24% |
| Mitsubishi UFJ Financial Group, Inc. MUFG $225K → $221K | −21% |
| Terminations 1 | Change |
|---|---|
| AstraZeneca AZN was $153K | −100% |
Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jul 31, 2026 (Form N-PORT) vs the portfolio of Apr 30, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed Sep 11, 2026.
Genter Capital International Dividend ETF's investment objective is to seek current income and long-term capital appreciation.
Principal investment strategies
Under normal market conditions, the Fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends. The Fund will invest primarily in companies with market capitalizations of $2 billion or higher at the time of initial purchase. In addition, the Fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors. Investments in and weightings of individual sectors will vary based on the Fund's investment sub-advisor's, RNC Capital Management, LLC d/b/a Genter Capital Management ("Genter Capital" or the "Sub-Advisor") assessment of valuation and the economic outlook using the process described below. Examples of conditions that will affect the weighting of sectors include recent relative performance of each sector to the overall market performance, economic conditions such as inflation and economic growth and expectations of economic growth in the upcoming period of time and how that sector might be affected more or less than other sectors, and economic growth rate and geopolitical conditions, military conflicts which can and typically affect availability and demand for natural resources that can have impact on one or more sectors relative to other sectors of the overall market economy. For example, the price of oil has a significant impact on the transportation sector, which can in turn have a significant impact on consumer goods and raw materials being transported. Another example which can have a significant impact on one or more sectors is tariffs. Tariffs imposed on either a country or a particular industry will increase the price and may reduce the supply as well. A tariff on consumer goods imported from China would impact retailers where those imported goods are sold. 2 The Fund defines foreign equity securities as equity securities of companies organized or having their principal place of business (location where they are subject to revenue tax) outside the U.S. The Fund's investments in foreign securities will primarily be in American Depository Receipts ("ADRs"), which are receipts that represent interests in foreign securities held on deposit by U.S. banks. The Fund may also invest up to 20% of its assets in domestic equity securities that have records of paying dividends and derive more than 30% of revenues from non-U.S. operations. The Sub-Advisor employs a three-step process in selecting the Fund's investments. The Sub-Advisor begins with a universe of those foreign publicly traded companies and domestic equity securities that derive more than 30% of revenues from non-U.S. operations that have paid a dividend in each of the previous four quarters. First, the Sub-Advisor uses publicly available filings, financial analyst's reports and research information available both publicly and by subscription or purchase to identify companies that have 1) market capitalizations greater than $2 billion, 2) dividend growth, which the Sub-Advisor defines as no quarters among the previous four with any dividend reduction and at least one of the most recent two quarters having a dividend increase, and 3) investment grade debt ratings. Second, a thorough fundamental analysis of the companies is conducted focusing on valuation and balance sheet and income statement information. Lastly, the three characteristics identified in the first step are evaluated further to view the dividend yield, assessment of likelihood of capital appreciation, and to assess the expected volatility and risk for each security.
Management and Contact
- Adviser
- OBP Capital LLC
- Sub-adviser
- Genter Capital Management
- Portfolio managers
-
David Pescherine, Senior Vice President of the Sub-Advisor, David P. Klatt, Vice President of the Sub-Advisor, and Glen Nam, First Vice President of the Sub-Advisor are the Fund's portfolio managers and are jointly and primarily responsible for the day-to-day management of the Fund's portfolio.
Mr. Pescherine, Mr. Klatt, and Mr. Nam have managed the Fund since its inception in January 2025.
- Phone
- 1-800-773-3863
- [email protected]
- Website
- genterfunds.com/GENW
Holdings as of Jul 31, 2026
The full portfolio as of the quarter end Jul 31, 2026, from the fund's report to the SEC (Form N-PORT, filed Sep 28, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Apr 30, 2026.
36 lines, 18 linked, weights sum to 100.14% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| Barclays PLC | BCS 06738E204 | Equity | 9,257 | 0 | 4.98% | $ 254.568K |
| Banco Bilbao Vizcaya | US05946K1016 | Equity | 8,121 | 0 | 4.44% | $ 226.982K |
|
ABB Limited
|
US0003752047 | Equity | 2,278 | 0 | 4.39% | $ 224.656K |
|
BNP Paribas SA
|
US05565A2024 | Equity | 3,554 | +550 | 4.39% | $ 224.719K |
| Mitsubishi UFJ Finan | US6068221042 | Equity | 9,863 | −2,645 | 4.33% | $ 221.424K |
| Sumitomo Mitsui Fina | US86562M2098 | Equity | 8,167 | −2,625 | 4.13% | $ 211.362K |
| Vodafone Group PLC | VOD 92857W308 | Equity | 10,660 | 0 | 3.29% | $ 168.215K |
| Enbridge Inc | CA29250N1050 | Equity | 3,037 | 0 | 3.23% | $ 165.395K |
|
Allianz SE
|
US0188201000 | Equity | 3,268 | 0 | 3.18% | $ 162.616K |
|
Enel SpA
|
US29265W2070 | Equity | 13,774 | 0 | 3.03% | $ 154.958K |
|
Orange SA
|
US6840601065 | Equity | 7,995 | 0 | 2.97% | $ 152.005K |
|
Imperial Brands PLC
|
US45262P1021 | Equity | 3,951 | +1,475 | 2.92% | $ 149.387K |
| Telefonaktiebolaget | ERIC 294821608 | Equity | 14,818 | 0 | 2.84% | $ 145.365K |
|
MERCEDES-BENZ GROUP
|
MBGYY 233825207 | Equity | 10,773 | +5,855 | 2.84% | $ 145.22K |
| Novartis AG | NVS 66987V109 | Equity | 925 | 0 | 2.82% | $ 144.439K |
|
BAE Systems PLC
|
US05523R1077 | Equity | 1,259 | 0 | 2.79% | $ 142.985K |
|
Carlsberg AS
|
US1427952023 | Equity | 4,790 | 0 | 2.78% | $ 142.455K |
| ORIX Corp | US6863301015 | Equity | 3,470 | 0 | 2.73% | $ 139.876K |
|
AstraZeneca PLC
|
AZN G0593M107 | Other | 819 | new +819 | 2.72% | $ 138.935K |
|
AXA SA
|
AXAHY 054536107 | Equity | 2,674 | 0 | 2.71% | $ 138.513K |
| British American Tob | BTI 110448107 | Equity | 2,265 | 0 | 2.68% | $ 137.372K |
| Manulife Financial C | CA56501R1064 | Equity | 2,971 | 0 | 2.58% | $ 132.031K |
| Nomura Holdings Inc | US65535H2085 | Equity | 13,473 | 0 | 2.55% | $ 130.419K |
| Rio Tinto PLC | RIO 767204100 | Equity | 1,321 | 0 | 2.50% | $ 127.939K |
| Pembina Pipeline Cor | PBA 706327103 | Equity | 2,542 | 0 | 2.43% | $ 124.38K |
|
Koninklijke Ahold De
|
US5004675014 | Equity | 3,070 | 0 | 2.36% | $ 120.528K |
| National Grid PLC | NGG 636274409 | Equity | 1,453 | 0 | 2.27% | $ 116.196K |
| BP PLC | BP 055622104 | Equity | 2,519 | 0 | 2.23% | $ 113.909K |
|
CK Hutchison Holding
|
US12562Y1001 | Equity | 11,683 | 0 | 2.14% | $ 109.353K |
|
Komatsu Ltd
|
US5004584018 | Equity | 2,113 | 0 | 1.79% | $ 91.641K |
|
Schneider Electric S
|
US80687P1066 | Equity | 1,356 | 0 | 1.78% | $ 90.96K |
| Honda Motor Co Ltd | US4381283088 | Equity | 2,872 | 0 | 1.69% | $ 86.476K |
|
DSM-Firmenich AG
|
US23346J1034 | Equity | 7,268 | 0 | 1.54% | $ 78.567K |
|
Akzo Nobel NV
|
US0101995035 | Equity | 3,273 | 0 | 1.49% | $ 76.326K |
| Sanofi | SNY 80105N105 | Equity | 1,651 | 0 | 1.39% | $ 71.125K |
|
Goldman Sachs Financ
|
FGTXX 38141W273 | Money market | 62,036.9 | −30,599.3 | 1.21% | $ 62.037K |
Trades Apr 30, 2026 to Jul 31, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|---|---|---|---|---|---|
| AstraZeneca PLC | AZN | Closed | 819 | — | −819 | $ -153.456K |
|
AstraZeneca PLC
|
AZN | New | — | 819 | +819 | $ 138.935K |
|
MERCEDES-BENZ GROUP
|
MBGYY | Bought | 4,918 | 10,773 | +5,855 | $ 78.925K |
| Sumitomo Mitsui Fina | Sold | 10,792 | 8,167 | −2,625 | $ -67.935K | |
| Mitsubishi UFJ Finan | Sold | 12,508 | 9,863 | −2,645 | $ -59.38K | |
|
Imperial Brands PLC
|
Bought | 2,476 | 3,951 | +1,475 | $ 55.77K | |
|
BNP Paribas SA
|
Bought | 3,004 | 3,554 | +550 | $ 34.777K |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up